Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Immune and Circulating Tumor DNA Profiling After Radiation Treatment for Oligometastatic Non-Small Cell Lung Cancer: Translational Correlatives from a Mature Randomized Phase II Trial

Translational correlative analysis of a randomized phase 2 oligometastatic NSCLC trial (NCT01725165): local consolidative therapy was associated with a lower early-follow-up ctDNA mutation count and VAF than maintenance/observation, and among six patients with serial ctDNA a rise preceded clinical progression by 6.7 months; baseline ctDNA metrics were not associated with outcomes.

Int J Radiat Oncol Biol PhysPubMed 31678224DOI 10.1016/j.ijrobp.2019.10.038